Idexx Laboratories (IDXX) Interest & Investment Income (2009 - 2026)

Idexx Laboratories has reported Interest & Investment Income for 17 years, with the latest figure at $606000.0 in Q2 2026.

• On a quarterly basis, Interest & Investment Income fell 3.35% year-over-year to $606000.0 in Q2 2026; TTM through Jun 2026 was $2.4 million, a 64.92% decrease from a year earlier, with the FY2025 full-year figure at $3.0 million, down 76.3% from the prior year.
• Interest & Investment Income was $606000.0 for Q2 2026 at Idexx Laboratories, up from $597000.0 in the prior quarter.
• The five-year high for Interest & Investment Income was $4.4 million in Q1 2024, with the low at $143000.0 in Q1 2022.
• Average Interest & Investment Income over 5 years is $1.3 million, with a median of $601500.0 recorded in 2026.
• The sharpest annual moves came in 2023 and 2025: Interest & Investment Income jumped 1445.11% in 2023, then tumbled 81.31% in 2025.
• Over 5 years, Interest & Investment Income stood at $235000.0 in 2022, then surged by 1445.11% to $3.6 million in 2023, then plunged by 39.44% to $2.2 million in 2024, then slumped by 73.31% to $587000.0 in 2025, then gained by 3.24% to $606000.0 in 2026.
• The last three Interest & Investment Income figures came in at $606000.0 (Q2 2026), $597000.0 (Q1 2026), and $587000.0 (Q4 2025), per Business Quant data.